Stay updated on Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Primary peritoneal carcinoma as a study condition and added the Genetic and Rare Diseases Information Center as a resource. Removed the government funding lapse notice and updated the page revision to v3.4.2.
    Difference
    0.6%
    Check dated 2026-02-11T04:14:02.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice regarding government funding and NIH Clinical Center operations was added. The page revision tag was updated to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:15:49.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page adds a glossary display option and updates metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), replacing the previous wording (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T03:49:55.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing Revision: v3.3.3. This appears to be a backend version update with no changes to the study details or user interactions on the page.
    Difference
    0.1%
    Check dated 2026-01-14T02:28:39.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Illinois locations under the Locations section. Revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:17:05.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The Publications section now states that entries are automatically filled from PubMed, and a revision tag v3.3.2 was added. The previous PubMed-origin description and the older revision tag v3.2.0 were removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:03:45.000Z thumbnail image

Stay in the know with updates to Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.